PATENT CLAIM ANALYSIS

Application Number: 16194762
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["546", "211000"]

Abstract:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which q, R 11 , R 12 , R 13  and R 14  are as defined in the specification, for use in therapy.

Claim (Index 3):
A method for the treatment of pain comprising administering to a patient in need thereof a therapeutically effective amount of the S-enantiomer of 4-((4-chlorophenyl)fluoromethyl)-1-((3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl)piperidine or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.27273
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15262436', '14402751', '15525417', '14893148', '15971330']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7563403585289904
- 35 USC 102 Novelty (BERT): 0.5427405294949905
- Combined Prediction Score: 0.7349803756255904
- Mean Citation Score: 354.105138
- Max Citation Score: 385.2781
- Similarity Product: 351.3795981184304

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test